Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (153)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Inotuzumab Ozogamicin	ADC	Hematologic
Molecule Inotuzumab Ozogamicin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Polatuzumab Vedotin	ADC	Hematologic
Molecule Polatuzumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Loncastuximab Tesirine	ADC	Hematologic
Molecule Loncastuximab Tesirine Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Belantamab Mafodotin	ADC	Hematologic
Molecule Belantamab Mafodotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Tafasitamab	ADC	Hematologic
Molecule Tafasitamab Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Naratuximab Emtansine	ADC	Hematologic
Molecule Naratuximab Emtansine Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Elotuzumab	Anti-CD38 / SLAMF7 mAb	Hematologic (Multiple Myeloma)
Molecule Elotuzumab Therapeutic Category Immunotherapy (Monoclonal Antibody) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
Daratumumab	Anti-CD38 / SLAMF7 mAb	Hematologic (Multiple Myeloma)
Molecule Daratumumab Therapeutic Category Immunotherapy (Monoclonal Antibody) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
Daratumumab + Hyaluronidase (SC)	Anti-CD38 / SLAMF7 mAb	Hematologic (Multiple Myeloma)
Molecule Daratumumab + Hyaluronidase (SC) Therapeutic Category Immunotherapy (Monoclonal Antibody) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
Isatuximab	Anti-CD38 / SLAMF7 mAb	Hematologic (Multiple Myeloma)
Molecule Isatuximab Therapeutic Category Immunotherapy (Monoclonal Antibody) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
Bortezomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Bortezomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Carfilzomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Carfilzomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor

Inotuzumab Ozogamicin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Polatuzumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Loncastuximab Tesirine Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Belantamab Mafodotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Tafasitamab Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Naratuximab Emtansine Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Hematologic Drug Class / Mechanism ADC
Elotuzumab Immunotherapy (Monoclonal Antibody)
Therapeutic Category Immunotherapy (Monoclonal Antibody) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
Daratumumab Immunotherapy (Monoclonal Antibody)
Therapeutic Category Immunotherapy (Monoclonal Antibody) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
Daratumumab + Hyaluronidase (SC) Immunotherapy (Monoclonal Antibody)
Therapeutic Category Immunotherapy (Monoclonal Antibody) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
Isatuximab Immunotherapy (Monoclonal Antibody)
Therapeutic Category Immunotherapy (Monoclonal Antibody) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Anti-CD38 / SLAMF7 mAb
Bortezomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
Carfilzomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor

‹ 1 … 3 4 5 6 7 … 13 ›

Product Range

Company

Global Network

Products

Inotuzumab Ozogamicin

Polatuzumab Vedotin

Loncastuximab Tesirine

Belantamab Mafodotin

Tafasitamab

Naratuximab Emtansine

Elotuzumab

Daratumumab

Daratumumab + Hyaluronidase (SC)

Isatuximab

Bortezomib

Carfilzomib

Inotuzumab Ozogamicin

Polatuzumab Vedotin

Loncastuximab Tesirine

Belantamab Mafodotin

Tafasitamab

Naratuximab Emtansine

Elotuzumab

Daratumumab

Daratumumab + Hyaluronidase (SC)

Isatuximab

Bortezomib

Carfilzomib